| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |